biote Corp. announced an amended and restated employment agreement for Interim CEO Robert Peterson, effective June 12, 2026. The agreement includes an annual base salary of $658,800, an annual incentive compensation eligibility of up to 72.5% of base salary, and stock option awards representing 0.56% of outstanding shares. biote Corp. is a medical technology company that provides biological and biological-based solutions for wellness and wellness-based products.